Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.22 CNY
267.91 M CNY
2.71 B CNY
26.00 M
About CHENGDU BRIGHT EYE
Sector
Industry
CEO
Qiang Sun
Website
Headquarters
Shanghai
Founded
2005
ISIN
CNE100005GX3
FIGI
BBG00WGGJL81
Chengdu Bright Eye Hospital Group Co., Ltd. engages in provision of general ophthalmic medical services such as diagnosis, treatment, health care, medical optometry and glasses for patients with eye diseases. The company was founded in 2005 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 301239 is 46.50 CNY — it has decreased by −1.44% in the past 24 hours. Watch CHENGDU BRIGHT EYE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange CHENGDU BRIGHT EYE stocks are traded under the ticker 301239.
301239 stock has fallen by −6.81% compared to the previous week, the month change is a −6.44% fall, over the last year CHENGDU BRIGHT EYE has showed a −44.72% decrease.
We've gathered analysts' opinions on CHENGDU BRIGHT EYE future price: according to them, 301239 price has a max estimate of 67.00 CNY and a min estimate of 67.00 CNY. Watch 301239 chart and read a more detailed CHENGDU BRIGHT EYE stock forecast: see what analysts think of CHENGDU BRIGHT EYE and suggest that you do with its stocks.
301239 reached its all-time high on May 16, 2023 with the price of 144.88 CNY, and its all-time low was 28.48 CNY and was reached on Sep 18, 2024. View more price dynamics on 301239 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
301239 stock is 4.28% volatile and has beta coefficient of 2.53. Track CHENGDU BRIGHT EYE stock price on the chart and check out the list of the most volatile stocks — is CHENGDU BRIGHT EYE there?
Yes, you can track CHENGDU BRIGHT EYE financials in yearly and quarterly reports right on TradingView.
CHENGDU BRIGHT EYE is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
301239 net income for the last quarter is −27.45 M CNY, while the quarter before that showed 26.37 M CNY of net income which accounts for −204.11% change. Track more CHENGDU BRIGHT EYE financial stats to get the full picture.
Yes, 301239 dividends are paid annually. The last dividend per share was 0.40 CNY. As of today, Dividend Yield (TTM)% is 0.85%. Tracking CHENGDU BRIGHT EYE dividends might help you take more informed decisions.
CHENGDU BRIGHT EYE dividend yield was 0.47% in 2023, and payout ratio reached 22.29%. The year before the numbers were 0.14% and 72.73% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 4.92 K employees. See our rating of the largest employees — is CHENGDU BRIGHT EYE on this list?
Like other stocks, 301239 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHENGDU BRIGHT EYE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHENGDU BRIGHT EYE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHENGDU BRIGHT EYE stock shows the sell signal. See more of CHENGDU BRIGHT EYE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.